| ICD-9-CM: |
| 200.1 - | Lymphosarcoma; Hodgkins Disease |
| 201 - | Hodgkins Disease; Lymphoma |
| 201.0 - | Hodgkins Paragranuloma |
| 201.00 - | Hodgkins Paragranuloma, Unspecified Site |
| 201.08 - | Hodgkins Paragranuloma, Lymph Nodes of Multiple Sites |
| 201.1 - | Hodgkins Granuloma |
| 201.10 - | Hodgkins Granuloma, Unspecified Site |
| 201.18 - | Hodgkins Granuloma, Lymph Nodes of Multiple Sites |
| 201.2 - | Hodgkins Sarcoma |
| 201.20 - | Hodgkins Sarcoma, Unspecified Site |
| 201.28 - | Hodgkins Sarcoma, Lymph Nodes of Multiple Sites |
| 201.4 - | Hodgkins Disease, Lymphocytic-histiocytic Predominance |
| 201.40 - | Hodgkins Disease, Lymphocytic-histiocytic Predominance, Unspecified Site |
| 201.48 - | Hodgkins Disease, Lymphocytic-histiocytic Predominance, Lymph Nodes of Multiple Sites |
| 201.5 - | Hodgkins Disease, Nodular Sclerosis |
| 201.50 - | Hodgkins Disease, Nodular Sclerosis, Unspecified Site |
| 201.58 - | Hodgkins Disease, Nodular Sclerosis, Lymph Nodes of Multiple Sites |
| 201.6 - | Hodgkins Disease, Mixed Cellularity |
| 201.60 - | Hodgkins Disease, Mixed Cellularity, Unspecified Site |
| 201.68 - | Hodgkins Disease, Mixed Cellularity, Lymph Nodes of Multiple Sites |
| 201.7 - | Hodgkins Disease, Lymphocytic Depletion |
| 201.70 - | Hodgkins Disease, Lymphocytic Depletion, Unspecified Site |
| 201.78 - | Hodgkins Disease, Lymphocytic Depletion, Lymph Nodes of Multiple Sites |
| 201.9 - | Hodgkins Disease, Unspecified |
| 201.90 - | Hodgkins Disease, Unspecified, Unspecified Site |
| 201.98 - | Hodgkins Disease, Unspecified, Lymph Nodes of Multiple Sites |
| Hodgkin's disease accounts for about 14% of cancers that develop in lymphatic tissue. All other types of lymph cancer are called non-Hodgkin's lymphomas. Lymphatic tissue includes lymph nodes connected throughout the body by a network of vessels, the spleen, thymus, and bone marrow. Lymph nodes make and store lymphocytes, a type of white blood cell. Lymphatic vessels transport the lymphocytes in a clear fluid called lymph to the bloodstream. Hodgkin's disease is caused by the development of an abnormal type of lymphocyte called a Reed-Sternberg cell. This cell divides rapidly and replicates uncontrollably, destroying the normal structure and function of the tissue within the lymphatic system.
Hodgkin's disease usually begins as a painless swelling of a lymph node, most commonly in the chest, neck, or underarms; it then spreads to adjoining nodes. It may also spread to the bloodstream and be carried to distant sites including the liver, lungs, and bone marrow.
There is no definitive cause for Hodgkin's disease, but it has been thought to be related to the same virus (Epstein-Barr virus) responsible for infectious mononucleosis. EBV is found in the lymph nodes of about 50% of individuals with Hodgkin's disease. Individuals who have had mononucleosis have about a fourfold increased risk of developing Hodgkin's disease. Individuals with reduced immunity because of HIV infection, immunosuppressive medication, or immune deficiency diseases may also have greater risk for Hodgkin's disease. A genetic predisposition has also been noted, as well as a relationship to certain human leukocyte (white blood cell) antigens (HLA).Risk: There may be a genetic predisposition toward Hodgkin's disease; about 1% of individuals with this condition will have a family history of the disease, and siblings of individuals with Hodgkin's disease have a greater risk of developing the disease ("Hodgkin's Disease").
The incidence of Hodgkin's disease is higher in men than in women by a ratio of 1.4 to 1 ("Hodgkin's Disease"). Hodgkin's disease is more common in whites than in blacks or Asians. Generally, Hodgkin's disease has a bimodal distribution, affecting predominantly young adults (15 to 34 years of age) or older individuals (50 years or older); peak incidence is between ages 20 and 24, and again between ages 80 and 84 ("Detailed Guide"; Kaufman 2620). Incidence and Prevalence: Hodgkin's disease affects 2.9 per 100,000 people in the US (Argiris). About 8,000 cases are diagnosed in the US each year, compared to 800 in Canada (Kaufman 2620). The incidence rate has been declining for over 20 years at a rate of about 0.9% per year ("Hodgkin's Disease"). Because of advances in treatment, the death rate has fallen more than 60% in the past 30 years ("Detailed Guide"). Incidence of Hodgkin's disease is 59,000 individuals worldwide (Argiris). |
Source: Medical Disability Advisor
| History: Individuals are often asymptomatic. Some will report a painless, swollen lump in the neck, groin (ilioinguinal-femoral region), or under the arm. Other will report vague symptoms such as persistent fever, weight loss, night sweats, itching (pruritus), and fatigue. Characteristically, the fever is cyclic (Pel-Ebstein fever) and may recur at variable intervals of several days to many weeks. Physical exam: Enlarged lymph nodes, nearly always in the neck or armpit but occasionally in the groin, are usually noted during physical examination. The nodes may be hard and stony or rubbery or soft. Enlargement of both the spleen (splenomegaly) and liver (hepatomegaly) may be noticed during palpation of the abdomen. If the cancer is advanced, large masses may appear on the neck, producing the "bull-neck" appearance characteristic of late-stage Hodgkin's disease. Tests: Blood tests include complete blood count (CBC) to evaluate numbers of red blood cells (RBCs) and white blood cells (WBCs), hemoglobin, and platelets. RBCs and hemoglobin may be reduced due to anemia. WBCs may be elevated as part of the immune system response to disease or inflammation. Blood chemistries such as blood protein (serum albumin), uric acid, and liver enzymes will be performed. An erythrocyte sedimentation rate (ESR) may be done to determine if inflammation is present.
Definitive diagnosis of Hodgkin's disease requires taking a sample of tissue (biopsy) from an enlarged lymph node, staining the tissue cells (immunohistochemical staining), and examining them under a microscope. A pathologist will examine the stained cells to identify Reed-Sternberg cells typical of Hodgkin's disease; staging of the disease can be done at the same time by classifying cells from different sites. The cells may be stained to identify molecules called CD15 and CD 30.
If the biopsy confirms the diagnosis of Hodgkin's disease, additional tests will be conducted. Other tests may include a chest x-ray (radiographic examination) to identify enlarged lymph nodes in the middle of the chest (mediastinal mass). A CT scan, MRI, positron emission tomography (PET), gallium scan, or an exploratory abdominal surgical procedure (laparotomy) may help determine if the disease has spread outside the lymph system. A sample of bone marrow (bone marrow biopsy) may reveal bone involvement. |
Source: Medical Disability Advisor
| In the past 30 years there have been advances in the treatment of HD which allow most newly diagnosed individuals to achieve cure with chemotherapy and/or radiation therapy. Complete cure is now the goal of treatment. Treatment depends upon the stage of the disease at diagnosis and the individual's age. Staging is based on clinical signs and symptoms, the number and location of affected nodes, whether nodes are on only one side of the diaphragm or both, and whether there is evidence of spreading to either bone marrow or spleen or outside the lymphatic system. |
Source: Medical Disability Advisor
| Hodgkin's disease responds very well to treatment. Overall, the 1-year survival rate is 91%, the 5-year survival rate is 84%, the 10-year survival rate is 76%, and the 15-year survival rate is 68% ("Detailed Guide"). Most recurrences are usually treated effectively with chemotherapy and/or radiation. Only 15% of individuals with Hodgkin's disease relapse following successful treatment with both chemotherapy and radiation (Argiris). After 15 to 20 years, individuals are more likely to die from a different type of malignancy than from a recurrence of Hodgkin's disease ("Detailed Guide"). |
Source: Medical Disability Advisor
| Rehabilitation for the individual who has undergone exploratory abdominal surgery (laparotomy) may include intermittent positive pressure breathing exercises that may help prevent postoperative pulmonary complications. Certain exercises may also be performed to reduce postoperative pain and speed recovery, including progressive relaxation and deep-breathing techniques. Individuals may continue with these exercises for 4 to 6 weeks until recovery from surgery is complete and pain is no longer noticeable while walking or breathing. |
Source: Medical Disability Advisor
| Complications of Hodgkin's disease can include lymph node enlargement or fluid accumulation in various locations in the body, resulting in the following emergency situations: obstruction of the airway, obstruction of the major vein that returns blood to the heart (superior vena caval obstruction), compression of the heart (pericardial tamponade), spinal cord compression, obstruction of the hepatic (liver) duct (extrahepatic biliary obstruction), or pressure on nerves in the head or periphery (cranial and peripheral neuropathies).
Complications of radiation treatment for Hodgkin's disease include development of secondary cancers such as acute nonlymphocytic leukemia, radiation-induced carcinomas and sarcomas, and non-Hodgkin's lymphoma. Additionally, radiation therapy to the neck region may result in an underactive thyroid (hypothyroidism) several years after treatment is completed.
Chemotherapy often results in acute, though reversible, toxicity leading to nausea, vomiting, and neurologic disorders. Infections may occur as a result of immunosuppression by chemotherapeutic agents being used in treatment or as a result of Hodgkin's disease itself. Other complications of chemotherapy may include heart or lung disorders and female infertility. |
Source: Medical Disability Advisor
| Individuals with Hodgkin's disease will experience high levels of fatigue with normal levels of physical exertion. Chemotherapy and radiation therapy can cause additional weakness and fatigue. Also, individuals who have exploratory abdominal surgery (laparotomy) may require more sedentary, nonphysical work for a period of time. Heavy physical labor is usually restricted following surgery (laparotomy), chemotherapy, and/or radiation therapy treatments. Work responsibilities may need to be modified until recovery is complete. |
Source: Medical Disability Advisor
| If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case. Regarding diagnosis:
- Does individual have a history of infectious mononucleosis caused by the Epstein-Barr virus (EBV)?
-
Is individual infected with the human immunodeficiency virus (HIV)?
-
Is there a family history of Hodgkin's disease?
-
Does individual report a painless mass in the neck, underarm area, or in the inner thigh area (ilioinguinal-femoral region)?
-
Has individual noted persistent fever, weight loss, night sweats, itching (pruritus), or fatigue?
-
Does individual report sudden, intense pain after alcohol ingestion?
-
Has a tissue sample (biopsy) been taken from an enlarged lymph node to make a definitive diagnosis of Hodgkin's disease?
-
Were x-rays of chest, liver, and spleen performed to identify location of involved lymph nodes? Was CT scan, MRI, PET, or exploratory abdominal surgical procedure (laparotomy) performed to determine the extent of the disease?
-
Was a bone marrow biopsy done to reveal the extent of bone involvement?
-
Were a complete blood count (CBC) and blood chemistries performed, including the measurement of serum albumin, uric acid, and liver enzymes?
-
Was the diagnosis of Hodgkin's disease confirmed?
Regarding treatment:
- What stage of the disease did individual have at time of diagnosis?
-
How did individual respond to the treatment? Was the treatment successful?
Regarding prognosis:
- Was treatment begun at an early stage of the disease?
-
Has the disease spread (metastasized) to other parts of the body?
-
Is this a recurrence (approximately 3 years after diagnosis) or a relapse (3 to 20 years after treatment)? Have complications resulted from chemotherapy and/or radiation therapy?
-
Has individual developed lymph node enlargement, causing compression or obstruction of other organs or nerves?
-
How will complications be treated, and what is the expected outcome with treatment?
-
Has individual experienced grossly enlarged lymph nodes (bull-neck), altering individual's appearance?
-
Have complications of the disease produced problems with individual's body image, self-esteem, and interpersonal relationships?
-
Would individual benefit from psychological counseling?
|
Source: Medical Disability Advisor
| Argiris, Athanassios, and Virginia Kaklamani. "Hodgkin Disease." eMedicine. Eds. Kaushik A. Shastri, et al. 2 Mar. 2004. Medscape. 1 Feb. 2005 <http://emedicine.com/med/topic1022.htm>. "Detailed Guide: Hodgkin's Disease." American Cancer Society. 1 Feb. 2005 <http://www.cancer.org>. "Hodgkin's Disease." MD Consult. Elsevier, Inc. 12 Oct. 2004 <http://home.mdconsult.com/das/stat/view/41552076-4/ctt?nid=109703&sid=280922653>. Kaufman, D., and D. Longo. "Hodgkin’s Disease." Clinical Oncology. Eds. Martin D. Abeloff, et al. 2nd ed. New York: Churchill Livingstone, Inc., 2620-2621. |
Source: Medical Disability Advisor
| Feedback |
| Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must
include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment.
If you are seeking medical advice, please contact your physician. Thank you! |
Send this comment to:
Sales
Customer Support
Content Development
|
|
| |
|
|
|
|
|
This publication is designed to provide accurate and authoritative information in
regard to the subject matter covered. It is published with the understanding that
the author, editors, and publisher are not engaged in rendering medical, legal,
accounting or other professional service. If medical, legal, or other expert assistance
is required, the service of a competent professional should be sought. We are unable to respond to requests for advice.
Any Sales inquiries should include an email address or other means of
communication.
|